Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Francia Reyes Silva"'
Autor:
Bijender Kumar, Vahid Afshar-Kharghan, Mayela Mendt, Robert Sackstein, Mark R. Tanner, Uday Popat, Jeremy Ramdial, May Daher, Juan Jimenez, Rafet Basar, Luciana Melo Garcia, Mayra Shanley, Mecit Kaplan, Xinhai Wan, Vandana Nandivada, Francia Reyes Silva, Vernikka Woods, April Gilbert, Ricardo Gonzalez-Delgado, Sunil Acharya, Paul Lin, Hind Rafei, Pinaki Prosad Banerjee, Elizabeth J. Shpall
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The current global platelet supply is often insufficient to meet all the transfusion needs of patients, in particular for those with alloimmune thrombocytopenia. To address this issue, we have developed a strategy employing a combination of approache
Externí odkaz:
https://doaj.org/article/2d172dab071b4742910d4a45a0b531a8
Autor:
Enli Liu, Sonny O. T. Ang, Lucila Kerbauy, Rafet Basar, Indreshpal Kaur, Mecit Kaplan, Li Li, Yijiu Tong, May Daher, Emily L. Ensley, Nadima Uprety, Ana Karen Nunez Cortes, Ryan Z. Yang, Ye Li, Hila Shaim, Francia Reyes Silva, Paul Lin, Vakul Mohanty, Sunil Acharya, Mayra Shanley, Luis Muniz-Feliciano, Pinaki P. Banerjee, Ken Chen, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Natural killer (NK) cells are innate lymphocytes recognized for their important role against tumor cells. NK cells expressing chimeric antigen receptors (CARs) have enhanced effector function against various type of cancer and are attractive contende
Externí odkaz:
https://doaj.org/article/84d792fb6aac47afad9d795bd2fc9ffe
Autor:
Mayela Mendt, May Daher, Rafet Basar, Mayra Shanley, Bijender Kumar, Francesca Lim Wei Inng, Sunil Acharya, Hila Shaim, Natalie Fowlkes, Jamie P. Tran, Elif Gokdemir, Nadima Uprety, Ana K. Nunez-Cortes, Emily Ensley, Thao Mai, Lucila N. Kerbauy, Luciana Melo-Garcia, Paul Lin, Yifei Shen, Vakul Mohanty, JunJun Lu, Sufang Li, Vandana Nandivada, Jing Wang, Pinaki Banerjee, Francia Reyes-Silva, Enli Liu, Sonny Ang, April Gilbert, Ye Li, Xinhai Wan, Jun Gu, Ming Zhao, Natalia Baran, Luis Muniz-Feliciano, Jeffrey Wilson, Indreshpal Kaur, Mihai Gagea, Marina Konopleva, David Marin, Guilin Tang, Ken Chen, Richard Champlin, Katayoun Rezvani, Elizabeth J. Shpall
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Acute graft-vs.-host (GVHD) disease remains a common complication of allogeneic stem cell transplantation with very poor outcomes once the disease becomes steroid refractory. Mesenchymal stem cells (MSCs) represent a promising therapeutic approach fo
Autor:
David Marin, Angelique Lin, Sean G. Yates, Nadima Uprety, Pinaki P. Banerjee, Mayela Mendt, Katayoun Rezvani, Qi Miao, Tamara Laskowski, Bingqian Hu, Sheetal S Rao, Ken Chen, Richard E. Champlin, Kimberly Klein, Duncan Mak, Fleur M. Aung, Elif Gokdemir, Paul Lin, Rafet Basar, Sunil Acharya, Emily Ensley, Indreshpal Kaur, Luis Muniz-Feliciano, Elizabeth J. Shpall, Fernando J. Martinez, Luciana Melo Garcia, May Daher, Jinzhuang Dou, Ye Li, Francia Reyes Silva, Sufang Li, Mayra Shanley, Hila Shaim
Publikováno v:
Cell Reports
Adoptive cell therapy with virus-specific T cells has been used successfully to treat life-threatening viral infections, supporting application of this approach to coronavirus disease 2019 (COVID-19). We expand severe acute respiratory syndrome coron
Autor:
Emily Ensley, Rafet Basar, Sufang Li, Kimberly Klein, Tamara Laskowski, May Daher, Jinzhuang Dou, Ye Li, Bingqian Hu, Mayela Mendt, Angelique Lin, Francia Reyes Silva, Richard E. Champlin, Duncan Mak, Katy Rezvani, Nadima Uprety, Sean G. Yates, Ken Chen, Mayra Shanley, Indreshpal Kaur, Paul Lin, Sheetal S Rao, Luciana Melo Garcia, Fleur M. Aung, Fernando J. Martinez, Hila Shaim, Luis Muniz-Feliciano, Elizabeth J. Shpall, David Marin, Sunil Acharya, Pinaki P. Banerjee, Elif Gokdemir
Publikováno v:
SSRN Electronic Journal.
Adoptive cell therapy with viral-specific T cells has been successfully used to treat life-threatening viral infections, supporting the application of this approach against COVID-19. We expanded SARS-CoV-2 T-cells from the peripheral blood of COVID-1